The Latest News in the Life Sciences
- Sanofi-Aventis (France) Board Said to Support Genzyme Corporation Bid of Up to $18.7 Billion
- FDA Advisory Committee Recommends Approval of AstraZeneca PLC's Brilinta (Ticagrelor) for Acute Coronary Syndromes; Lifts Forecast Due to Ruling
- <b>Shionogi Inc.</b> Announces FDA Approval of CUVPOSA for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions
- Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) Announces Upcoming Investor Conference Presentations
- Abbott Laboratories's SIMCOR(R) (Niacin Extended-Release/Simvastatin ) Receives FDA Approval for New Dosage Strengths
- Allergan Inc. Eye Drug Wins EU OK For Fluid Buildup
- Omeros Corporation Secures $40 Million Committed Equity Financing Facility
- Aptuit, Inc. and Siena Biotech S.p.A. Announce Strategic Relationship in Italy; Takes Minor Slice of Italian R&D Operations
- Isis Pharmaceuticals, Inc. Earns $5 Million Milestone Payment From GlaxoSmithKline for Designation of a Development Candidate to Treat an Undisclosed Rare and Serious Disease
- <b>CMP Therapeutics</b> Appoints <b>Dr. Neill Moray Mackenzie</b> as CEO
- <b>Kangmei Pharma</b> Invests $44 Million In 2 TCM Companies
- <b>CT Atlantic AG</b> Announces Appointment of <b>Michael Hocker</b> To CEO
- Grifols H1 Sales Meet Forecasts, Net Profit Misses
- Celgene Earnings Top Expectations, Shares Jump
- Eli Lilly and Company Loses Appeal in Gemzar Patent Case
- Sanofi-Aventis (France) Q2 Net up 61 Percent
- Wyeth and Waste Management Firm Face Eur 12 Million in Fines